We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire.
HONG KONG, Aug. 1, 2025 /PRNewswire/ -- MemeStrategy, Inc. ("MemeStrategy" or "the Company," Stock Code: 2440.HK), Asia's first publicly listed digital asset company, and...
HONG KONG, Aug. 1, 2025 /PRNewswire/ -- RWA Group Limited, a leading real-world asset (RWA) tokenization and infrastructure service provider based in Hong Kong,...
PLEASANTON, Calif., Aug. 1, 2025 /PRNewswire/ -- DermRays, a leader in professional-grade at-home hair removal solutions, today announced a major upgrade to its Revive...
TAIPEI, Aug. 1, 2025 /PRNewswire/ -- Taiwan Universe BioMedicine (TaiU), a startup spun off from the National Health Research Institutes (NHRI), today announced the completion...